Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. - Wikidata - awgldk - TriplyDB

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis.

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis.

http://www.wikidata.org/entity/Q44324816

about

Effect of cyclosporine on blood pressure An Alternative Approach to Atopic Dermatitis: Part II—Summary of Cases and Discussion Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010.Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity Serum mucosa-associated epithelial chemokine in atopic dermatitis: a specific marker for severity Therapeutic perspectives in atopic dermatitis.Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.Immunotherapy in atopic dermatitis.Systemic therapy of atopic dermatitis.Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis.Topical tacrolimus in the treatment of atopic dermatitis.Azathioprine for atopic dermatitis.Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology.Long-term safety of tacrolimus ointment in children treated for atopic dermatitis.Effect of cyclosporin A on the allergen-induced late asthmatic reaction.Do patient-reported outcomes have a role in the management of patients with cystic fibrosis?Dietary treatment of childhood atopic eczema/dermatitis syndrome (AEDS).Eczema in pregnancy.A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.The use of ciclosporin in psoriasis.Recent developments in the treatment of adult atopic dermatitis.Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis.Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London.Management of itch in atopic dermatitis.Pathways to managing atopic dermatitis: consensus from the experts Systemic Treatment of Adult Atopic Dermatitis: A Review.Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology.An update on current pharmacotherapy options in atopic dermatitis.Treatment of Eczema: Corticosteroids and Beyond.Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016.What is the evidence base for atopic eczema treatments? A summary of published randomized controlled trials.Review of Systemic Treatment Options for Adult Atopic Dermatitis.Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.FK-506--a novel immunosuppressant.Cyclosporin treatment of atopic dermatitis: five case studies and literature review.Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study.Immunologic basis of chronic allergic diseases: clinical messages from the laboratory bench.

P2860

Q24240463-FC9A7332-E64C-4249-89C7-AC2B5DA2DF7A Q24806074-4A33D292-786F-4352-8EC6-46C8BBC57CAC Q26799532-045A9AD6-D8A9-4DBD-B6F0-5D961E4E7257 Q27691377-20328DA1-4895-4F85-8FBC-B2FF242D7B13 Q28362822-AC386A0C-FA1D-447F-BF8C-DE9F9F70232B Q33607633-827DC7B6-422A-4BEF-9705-4999332E8295 Q33874346-CA68C517-969B-4DAB-B098-5376A6569873 Q34006054-6BAB8F6F-2154-4B81-B06E-CEBFAF36A3CA Q34104585-B92E8FE1-94AA-41EA-81EA-6F82BE0FFE79 Q34106943-AD3BF72D-9AEB-490A-B292-5ACE9306C742 Q34229692-32EA6BD4-0263-4638-9C64-AAE9D4F32225 Q34240736-B109AA85-544D-4C67-ABB6-BFD825B07321 Q34325861-BFF143B8-836C-42E5-B054-BBEC375F83F8 Q34328070-6C10566F-8621-4682-8AB4-E39D40FA23AF Q35015840-4404AB8F-B0EC-4086-A316-4337B9C9C910 Q35208400-6740B7A3-54FC-4043-9490-2F2F313D9524 Q35563577-9E117F0F-DA38-4575-B74E-4DBBC04D1DCE Q35820010-DC7CB1CC-9AE9-40C9-82B5-9FD159D27628 Q35831650-4F08F85B-E096-476F-9DBD-0E51F093F5D5 Q35902580-F888B4B5-6660-4D0E-9784-A5134C644359 Q36367867-F726CD0D-4F0E-473B-91EF-27E710EA29BF Q36374570-59E8E8A1-8F74-40C9-9BEF-D2DF1FC67FDA Q36459429-7042D47C-1F46-4BA7-A9E8-87D13D245E16 Q36797258-66836EAD-D1F6-4330-B706-445951221B89 Q36902986-B4284348-4049-40A5-8E2B-D09AA7DF6261 Q36991444-D722D63C-F5BD-4ED3-9B29-139F632E74BB Q37258723-158FB8E8-86E1-41A2-BF48-51B316CC5BFE Q37679948-894536CA-BE9B-4806-9B26-3FEDA65F6CB1 Q37936458-1EFF7D14-542D-40DF-BDCE-8B401408F869 Q38210447-C2879DAA-5F43-47EA-B348-7E64EB25519A Q38419338-B7859E7D-E2D2-4E19-9BE7-69F494EEAA3F Q38807878-85DB0AFF-6666-4697-9F3F-0D1823841FC7 Q38933737-2EB50FEE-3BB6-49FB-9E34-FF4564408FFA Q38956008-C8D84616-BFC5-44F1-ACD8-A92B5B8C80EA Q38988270-D1A03823-D26F-42A0-AA37-9E90ACEFBFE0 Q39165518-DBC8E1FA-FE8B-4D75-8833-5B846EE8D45E Q40489670-9C721551-EB76-4E45-B0FF-B6B1A2CF446E Q40498032-F64A8D7F-80EA-41B2-9971-090BF07C849D Q40619262-67B010EF-6AF3-4828-97FB-C2A0339AE34D Q40878733-7A5D1DC4-D203-4012-AEC0-93FB9290DC89

P2860

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis.

http://www.wikidata.org/entity/Q44324816

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年学术文章

@wuu

1991年学术文章

@zh

1991年学术文章

@zh-cn

1991年学术文章

@zh-hans

1991年学术文章

@zh-my

1991年学术文章

@zh-sg

1991年學術文章

@yue

1991年學術文章

@zh-hant

name

Double-blind, controlled, cros ...... refractory atopic dermatitis.

@en

Double-blind, controlled, cros ...... refractory atopic dermatitis.

@nl

type

label

Double-blind, controlled, cros ...... refractory atopic dermatitis.

@en

Double-blind, controlled, cros ...... refractory atopic dermatitis.

@nl

prefLabel

Double-blind, controlled, cros ...... refractory atopic dermatitis.

@en

Double-blind, controlled, cros ...... refractory atopic dermatitis.

@nl

P1433

Q44324816-B9BC2DAE-CCCC-459F-BD15-A75A9A604BE3

P1476

Q44324816-DC75F66A-7EFA-4C5B-B6DB-8FD054AC6813

P2093

Q44324816-1457C6F1-A2A0-470A-9CA7-E521588DAE74

Q44324816-2C00D3C1-1588-4B37-9FA2-79D66B4F62DE

Q44324816-7B594327-F70F-4E79-BD35-3029D27BAC92

Q44324816-8AB8AE84-476E-404B-A290-49DBE2D7080C

Q44324816-9C9EFF0F-8A48-4334-84B7-97E9D8F92426

Q44324816-BE8E325B-A244-4504-B3B6-596A90A3364C

Q44324816-CB8206DB-8CDC-45D0-BB3D-B865384333A7

Q44324816-D3F040E2-129F-41F5-9372-0AA898727926

Q44324816-EEC1B69C-EC28-4CF5-85F2-1DCA6C0FE1BE

Q44324816-F8483251-089D-402F-9997-3EE23B906E11

P304

Q44324816-949471D3-29D3-46B4-9F3D-E784EEB5547D

P31

Q44324816-26DE64A9-D308-4548-96E9-CE894F20E299

P356

Q44324816-0BBBCA6F-F273-4075-8DD8-25A7F33AEDB6

P407

Q44324816-2F6C60B3-0698-436C-A219-864DB337972A

P433

Q44324816-395AD215-FB87-4573-A1D0-9E462606170E

P478

Q44324816-0BC45B17-AD44-44F4-99D3-209E89EE8854

P577

Q44324816-A548EAC1-7DB1-4CBC-9FC4-A567E0FDBFA8

P698

Q44324816-A0507AF7-0C7D-4764-93E0-A3BA03B70F0E

P356

0140-6736(91)90134-B

P1433

P1476

Double-blind, controlled, cros ...... refractory atopic dermatitis.

@en

P2093

A Y Finlay

http://www.w3.org/2001/XMLSchema#string

B R Allen

http://www.w3.org/2001/XMLSchema#string

J Berth-Jones

http://www.w3.org/2001/XMLSchema#string

J M Sowden

http://www.w3.org/2001/XMLSchema#string

J S Ross

http://www.w3.org/2001/XMLSchema#string

M S Salek

http://www.w3.org/2001/XMLSchema#string

R A Graham-Brown

http://www.w3.org/2001/XMLSchema#string

R D Camp

http://www.w3.org/2001/XMLSchema#string

R J Motley

http://www.w3.org/2001/XMLSchema#string

R Marks

http://www.w3.org/2001/XMLSchema#string

P304

137-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0140-6736(91)90134-B

http://www.w3.org/2001/XMLSchema#string

P407

P433

8760

http://www.w3.org/2001/XMLSchema#string

P478

338

http://www.w3.org/2001/XMLSchema#string

P577

1991-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1677063

http://www.w3.org/2001/XMLSchema#string